Yahoo
Stockholm - Delayed Quote SEK

ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)

0.9280 -0.0720 (-7.20%)
At close: November 6 at 5:21:20 PM GMT+1
View in AlphaSpace Currency in SEK All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
3,837
3,657
3,013
7,050
5,086
Cost of Revenue
3,499
3,520
5,681
3,647
5,081
Gross Profit
338
137
-2,668
3,403
5
Operating Expense
44,177
44,407
65,027
109,368
127,611
Operating Income
-43,839
-44,270
-67,695
-105,965
-127,606
Net Non Operating Interest Income Expense
274
91
987
1,410
1,025
Pretax Income
-43,565
-44,179
-44,563
-99,967
-126,581
Tax Provision
-7,654
-6,094
-8,525
-8,566
-7,976
Net Income Common Stockholders
-35,911
-38,085
-36,038
-91,401
-118,605
Diluted NI Available to Com Stockholders
-35,911
-38,085
-36,038
-91,401
-118,605
Basic EPS
-3.32
-3.85
-4.84
-21.71
-35.81
Diluted EPS
-3.32
-3.85
-4.84
-21.71
-35.81
Basic Average Shares
23,748.9830
9,883.2800
7,442.3350
4,210.0960
3,311.9270
Diluted Average Shares
23,748.9830
9,883.2800
7,442.3350
4,210.0960
3,311.9270
Total Operating Income as Reported
-43,839
-44,270
-67,695
-105,965
-127,606
Total Expenses
47,676
47,927
70,708
113,015
132,692
Net Income from Continuing & Discontinued Operation
-35,911
-38,085
-36,038
-91,401
-118,605
Normalized Income
-35,911
-38,085
-36,038
-91,401
-118,605
Interest Income
436
542
1,714
1,911
1,896
Interest Expense
162
451
727
501
871
Net Interest Income
274
91
987
1,410
1,025
EBIT
-43,403
-43,728
-43,836
-99,466
-125,710
EBITDA
-42,185
-42,261
-42,195
-97,865
-124,494
Reconciled Cost of Revenue
3,499
3,520
5,681
3,647
5,081
Reconciled Depreciation
1,218
1,467
1,641
1,599
1,216
Net Income from Continuing Operation Net Minority Interest
-35,911
-38,085
-36,038
-91,401
-118,605
Normalized EBITDA
-42,185
-42,261
-42,195
-97,865
-124,494
Tax Rate for Calcs
0.0002
0.0001
0.0002
0.0001
0.0001
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 7/29/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: